Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Nicolas C. Issa, Simon Doss-Gollin et al.|Open Forum Infectious Diseases|2022Cited by 10